For health organisations, the EU Parliament’s public health committee’s (ENVI) agreed compromise on the revision of the EUs pharmaceutical legislation could go further.
The Belgians have a packed in-tray as they take over at the helm of the EU Council Presidency in January, as they aim to cover a broad array of health topics and close key files before the European elections take over the agenda in June.
Following competitiveness concerns from industry over the EU’s pharmaceutical legislation, Austria and Germany added fuel to the fire by bringing the topic to EU ministers in the Competitiveness Council on Monday (25 September).
